Galectin 3 (encoded by LGALS3) promotes the interaction between cancer and stromal cells through the secretion of proinflammatory cytokines and the activation of integrin signaling [52], also suppressing immune surveillance via the regulation of T cell and natural killer cell functions [53]. Here, LGALS3 is linked to cancer.